Cargando…

Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers

BACKGROUND: Rates of thrombolysis in most countries are well below best practice benchmarks. We aimed to investigate thrombolysis utilization and its associated factors in acute ischemic stroke (AIS) patients in Hubei province, China, to assess neurologists’ experiences of the treatment, and to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yanfeng, Yan, Shijiao, Song, Xingyue, Gong, Yanhong, Li, Wenzhen, Wang, Mengdie, Yin, Xiaoxv, Hu, Bo, Lu, Zuxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704516/
https://www.ncbi.nlm.nih.gov/pubmed/31438899
http://dx.doi.org/10.1186/s12883-019-1418-z
_version_ 1783445516756975616
author Zhou, Yanfeng
Yan, Shijiao
Song, Xingyue
Gong, Yanhong
Li, Wenzhen
Wang, Mengdie
Yin, Xiaoxv
Hu, Bo
Lu, Zuxun
author_facet Zhou, Yanfeng
Yan, Shijiao
Song, Xingyue
Gong, Yanhong
Li, Wenzhen
Wang, Mengdie
Yin, Xiaoxv
Hu, Bo
Lu, Zuxun
author_sort Zhou, Yanfeng
collection PubMed
description BACKGROUND: Rates of thrombolysis in most countries are well below best practice benchmarks. We aimed to investigate thrombolysis utilization and its associated factors in acute ischemic stroke (AIS) patients in Hubei province, China, to assess neurologists’ experiences of the treatment, and to identify barriers against the treatment from perspective of AIS patients and neurologists. METHODS: Survey of 2096 AIS patients and 709 neurologists from 66 hospitals was conducted in Hubei province between 2014 and 2015. A multivariable logistic regression model was utilized to identify the factors associated with thrombolysis utilization and neurologists’ experiences with thrombolysis. RESULTS: Of the 2096 AIS patients, only 3.8% received thrombolysis. Of the 709 neurologists, 66.0% reported using thrombolysis for AIS patients. The main reasons for not using thrombolysis were late arrival of patients, fear of the risk of complications of thrombolysis, and light or quickly recovered stroke symptoms. The behavior and clinical characteristics of patients, including early admission to hospital (odds ratio [OR] = 5.81, 95% confidence intervals [CI] 3.31–10.20), using emergency medical services to be hospitalized (OR = 3.36, 95% CI 2.00–5.62), stroke history (OR = 0.53, 95% CI 0.28–0.99), and National Institute of Health Stroke Scale score < 4 (OR = 0.46, 95% CI 0.27–0.77) were shown to significantly affect the thrombolysis utilization in the multivariate model. In addition, hospital grade (OR = 2.84, 95% CI 1.84–4.37), education level (OR = 2.49, 95% CI 1.09–5.73), and working years (OR = 1.88, 95% CI 1.18–3.00) were strongly associated with neurologists’ experiences of thrombolysis. CONCLUSIONS: A very low proportion of AIS patients received thrombolysis in Hubei province, China. Considerable education programs and interventions were required regarding knowledge of stroke treatment for clinicians and proper behavior after stroke for AIS patients and their families. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-019-1418-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6704516
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67045162019-08-22 Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers Zhou, Yanfeng Yan, Shijiao Song, Xingyue Gong, Yanhong Li, Wenzhen Wang, Mengdie Yin, Xiaoxv Hu, Bo Lu, Zuxun BMC Neurol Research Article BACKGROUND: Rates of thrombolysis in most countries are well below best practice benchmarks. We aimed to investigate thrombolysis utilization and its associated factors in acute ischemic stroke (AIS) patients in Hubei province, China, to assess neurologists’ experiences of the treatment, and to identify barriers against the treatment from perspective of AIS patients and neurologists. METHODS: Survey of 2096 AIS patients and 709 neurologists from 66 hospitals was conducted in Hubei province between 2014 and 2015. A multivariable logistic regression model was utilized to identify the factors associated with thrombolysis utilization and neurologists’ experiences with thrombolysis. RESULTS: Of the 2096 AIS patients, only 3.8% received thrombolysis. Of the 709 neurologists, 66.0% reported using thrombolysis for AIS patients. The main reasons for not using thrombolysis were late arrival of patients, fear of the risk of complications of thrombolysis, and light or quickly recovered stroke symptoms. The behavior and clinical characteristics of patients, including early admission to hospital (odds ratio [OR] = 5.81, 95% confidence intervals [CI] 3.31–10.20), using emergency medical services to be hospitalized (OR = 3.36, 95% CI 2.00–5.62), stroke history (OR = 0.53, 95% CI 0.28–0.99), and National Institute of Health Stroke Scale score < 4 (OR = 0.46, 95% CI 0.27–0.77) were shown to significantly affect the thrombolysis utilization in the multivariate model. In addition, hospital grade (OR = 2.84, 95% CI 1.84–4.37), education level (OR = 2.49, 95% CI 1.09–5.73), and working years (OR = 1.88, 95% CI 1.18–3.00) were strongly associated with neurologists’ experiences of thrombolysis. CONCLUSIONS: A very low proportion of AIS patients received thrombolysis in Hubei province, China. Considerable education programs and interventions were required regarding knowledge of stroke treatment for clinicians and proper behavior after stroke for AIS patients and their families. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12883-019-1418-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-22 /pmc/articles/PMC6704516/ /pubmed/31438899 http://dx.doi.org/10.1186/s12883-019-1418-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhou, Yanfeng
Yan, Shijiao
Song, Xingyue
Gong, Yanhong
Li, Wenzhen
Wang, Mengdie
Yin, Xiaoxv
Hu, Bo
Lu, Zuxun
Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
title Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
title_full Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
title_fullStr Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
title_full_unstemmed Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
title_short Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
title_sort intravenous thrombolytic therapy for acute ischemic stroke in hubei, china: a survey of thrombolysis rate and barriers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704516/
https://www.ncbi.nlm.nih.gov/pubmed/31438899
http://dx.doi.org/10.1186/s12883-019-1418-z
work_keys_str_mv AT zhouyanfeng intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers
AT yanshijiao intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers
AT songxingyue intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers
AT gongyanhong intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers
AT liwenzhen intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers
AT wangmengdie intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers
AT yinxiaoxv intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers
AT hubo intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers
AT luzuxun intravenousthrombolytictherapyforacuteischemicstrokeinhubeichinaasurveyofthrombolysisrateandbarriers